Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-TargetLaurent Peyrin‐Biroulet, Brian G. Feagan, Gionata Fiorino et al.|The American Journal of Gastroenterology|2015Cited by 1.8k
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel diseaseNicholas T. Ventham, Louise Evenden, Nicholas A. Kennedy et al.|Nature Communications|2016Cited by 273
Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel DiseasesMirna Šimurina, T. L. Gilchrist, Noortje de Haan et al.|Gastroenterology|2018Cited by 164
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel diseaseMarisa Iborra, Silvio Danese, Francesca Bernuzzi et al.|Clinical & Experimental Immunology|2013Cited by 130
The PROSIT-BIO CohortGionata Fiorino, Vito Annese, Natalia Manetti et al.|Inflammatory Bowel Diseases|2017Cited by 126